Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
Clinical trial NCT05218668 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05218668
- Sponsor
- Woolsey Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-22
- Primary completion
- 2026-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.